Chemical SOP
Microbiology SOP
Warehouse SOP
Manufacturing SOP
Information technology SOP

CRITICAL CONTROL PRAMETERS AND CRITICAL QUALITY ATTRIBUTES IN PHARMA

A Critical Process Parameter (CPP) is a term used in pharmaceutical production for process variables which have an impact on a critical quality attribute (CQA) and, therefore, should be monitored or controlled to ensure the drug product obtains the desired quality.

  1. CPP & CQA of Tablets & Hard gel Capsules
  2. CPP & CQA of DPI
  3. CPP & CQA of Ophthalmics
  4. CPP & CQA of Ampoules
  5. CPP & CQA of FFS
  6. CPP & CQA of LVP
  7. CPP & CQA of Ointments
  8. CPP & CQA of Oral Liquids

Key CQA’s by Dosage Form

Dosage FormMain CQAs (Critical Quality Attributes)
TabletsIdentity, Assay, Content uniformity, Dissolution, Degradation products, Hardness/friability (if impacts performance), Water content, Microbial limits, Appearance (chipping, capping, spots)
Hard Gelatine CapsulesIdentity, Assay, Fill weight, Content uniformity, Dissolution / disintegration, Degradation products, Moisture (shell & fill), Shell integrity/brittleness, Microbial limits, Appearance (cracks, splits, printed text)
Soft Gelatine CapsulesIdentity, Assay, Fill volume, Content uniformity, Dissolution / disintegration, Degradation products, Moisture content, Leak test / seam integrity, Peroxide value (for oils), Microbial limits, Appearance (shape, sticking, oil leakage)
Sachets (Powder/Granules)Identity, Assay, Fill weight, Content uniformity (per sachet), Dissolution / reconstitution, Particle size (if performance related), Moisture content, Degradation products, Microbial limits, Foil/seal integrity, Appearance (caking, lumps)
DPI (Dry Powder Inhaler)Delivered dose uniformity, Emitted dose, Aerodynamic particle size distribution (fine particle fraction), Assay, Moisture content, Degradation products, Microbial limits, Device performance (actuation, dose counter), Content per blister/capsule, Appearance (powder flow)
Ophthalmics (Sterile)Sterility, Bacterial endotoxin, Assay, Degradation products, pH, Osmolality/tonicity, Particulate matter, Preservative content (multi-dose), Viscosity, Drop size, Clarity, Container-closure integrity
Ampoules / LVP (Parenteral solutions)Sterility, Bacterial endotoxin, Particulate matter (visible & sub-visible), Assay, Degradation products, pH, Osmolarity, Clarity, Container-closure integrity, Fill volume, Leachables (if applicable)
Ointments / CreamsAssay, Content uniformity (uniformity of dosage units), Degradation products, Microbial limits (topical) / Sterility (ophthalmic), Particle size (grittiness), Viscosity/spreadability, Phase uniformity (no separation), Appearance, pH (for creams/gels)
Oral Liquid Syrup/SuspensionAssay, Content uniformity, pH, Degradation products, Microbial limits, Preservative content, Viscosity, Clarity (solutions), Redispersibility (suspensions), Sedimentation volume, Organoleptic properties (colour, taste, odour), Appearance (no precipitation)

Use this as a master CQA list when you build your QTPP–CQA–CPP mapping.


CCP / Critical Steps – by Dosage Form

These are process steps that are “CCP-like” – where failure can critically impact CQAs and often can’t be fully corrected later.


A. Tablets

Key CQAs to protect: Assay, CU, Dissolution, Impurities, Hardness/friability, Appearance, Microbial limits

Typical CCPs / critical steps:

  • Dispensing & Sifting
    • Correct weight, segregation avoidance, foreign particle control → protects assay, CU, impurities
  • Blending / Lubrication
    • Blend time, speed, fill level, order of addition → content uniformity, assay
    • Over-lubrication → poor dissolution, low hardness
  • Granulation (Wet / Dry / Roller)
    • Granulation endpoint (LOD, torque), binder solution addition, impeller/chopper speed → dissolution, hardness, CU
  • Drying
    • Product temperature, drying time, LOD → stability, dissolution, impurities
  • Milling / Sizing
    • Screen size, mill speed → flow, CU, dissolution
  • Compression
    • Compression force, pre-compression, turret speed, weight control → hardness, friability, thickness, CU, appearance
  • Coating
    • Inlet temp, pan speed, spray rate, atomization pressure, weight gain → stability, appearance, dissolution (for functional coat)
  • Primary Packaging
    • Blister/strip sealing temp & pressure, leak test → moisture-sensitive CQAs, stability

B. Hard Gel Capsules

Key CQAs: Assay, CU, Dissolution, Moisture (shell/fill), Shell integrity, Microbial limits

Critical steps / CCPs:

  • Blend Preparation
    • Similar to tablets – uniformity & flow → CU, assay
  • Capsule Shell Storage
    • Temperature & humidity control → prevents brittleness or softening → shell integrity, dissolution
  • Capsule Filling
    • Machine speed, dosing disk/pin setting, tamping force → fill weight, CU
  • Metal check / sieving of filled capsules
    • Foreign matter → patient safety
  • Polishing / Dedusting
    • Remove loose powder → appearance, cross-contamination risk
  • Printing & Packaging
    • Correct print, no mix-ups, proper blistering/bottling → identification, stability

C. Soft Gel Capsules

Key CQAs: Assay, CU, Fill volume, Dissolution, Moisture, Seam integrity, Leaks, Peroxide value, Microbial limits

Critical steps / CCPs:

  • Gel Mass Preparation
    • Gelatin grade, plasticizer ratio, temperature, deaeration → shell strength, elasticity
  • Fill Formulation Preparation
    • Temperature, viscosity, antioxidant level → assay, uniformity, stability
  • Encapsulation (Rotary die process)
    • Ribbon thickness, sealing temperature, timing, alignment → seam integrity, leak rate, fill volume
  • Drying / Tumble Drying / Tray Drying
    • Time, temperature, airflow, RH → moisture content, shell hardness, brittleness
  • Leak Test / Weight Check
    • Detection of micro-leaks & variation → CU, stability
  • Packaging (Blisters / Bottles)
    • Protection from moisture, oxygen, light → impurities, peroxide value

D. Sachets (Powder / Granules)

Key CQAs: Assay, CU per sachet, Fill weight, Moisture, Dissolution, Impurities, Microbial limits, Foil integrity

Critical steps / CCPs:

  • Blend / Granules Preparation
    • Uniform mixing, appropriate particle size → CU, flow, dissolution
  • Environmental Conditions in Filling Area
    • RH & temp control to avoid clumping, moisture uptake → moisture, dissolution, appearance
  • Sachet Filling Operation
    • Auger/volumetric filler setting, line speed, vibration → fill weight, CU
  • Sealing
    • Jaw temperature, pressure, dwell time → seal integrity, moisture ingress
  • Online Checks
    • Net weight, seal integrity, leak test → directly protect dose, stability

E. DPI (Dry Powder Inhalers)

Key CQAs: Delivered dose uniformity, Emitted dose, APSD/FPF, Assay, Moisture, Device performance

Critical steps / CCPs:

  • API Micronization / Milling
    • Mill type, speed, feed rate, classifier settings → particle size distribution, hence FPF, lung deposition
  • Blending (API + Carrier like lactose)
    • Blender type, speed, time, load → adhesion of API to carrier, CU, DDU
  • Capsule/Blister Filling
    • Low-dose filling accuracy, vibration, de-aeration → delivered dose uniformity
  • Device Assembly
    • Correct fit of components, piercing mechanism, dose counter → device performance, DDU
  • Environmental Control
    • Dry conditions to avoid agglomeration → flow, dose emission
  • Packaging
    • Moisture-barrier packs, desiccants → moisture-sensitive aerosol performance

F. Ophthalmic Products (Solutions/Suspensions – Sterile)

Key CQAs: Sterility, Endotoxin, Assay, Impurities, pH, Osmolality, Particulate matter, Preservative level, Viscosity, Drop size, Clarity, CCI

Critical steps / CCPs:

  • Water & Raw Materials (Incoming)
    • WFI quality, bioburden control → baseline for sterility/endotoxin
  • Solution / Suspension Preparation
    • Order of addition, mixing speed, temperature, pH adjustment → assay, stability, particulate matter
  • Sterile Filtration (0.22 µm)
    • Filter integrity test (pre & post), pressure, time → sterility, particulates
  • Container Preparation
    • Washing, siliconization (if any), depyrogenation/sterilization → particulates, endotoxin, sterility
  • Aseptic Filling & Stoppering/Capping
    • Grade A conditions, interventions control, line speed, stopper feed → sterility, particulates, CCI
  • Terminal Sterilization (if used)
    • Cycle parameters, F₀, heat distribution → sterility, degradation
  • Preservative Efficacy (for multi-dose)
    • Correct preservative concentration → antimicrobial effectiveness
  • Visual Inspection
    • Particles, container defects, fill volume → appearance, particulate matter

G. Ampoules & LVP (Large Volume Parenterals)

Key CQAs: Sterility, Endotoxin, Particulates, Assay, pH, Osmolarity, Clarity, CCI, Fill volume, Degradation products

Critical steps / CCPs:

  • WFI Generation, Storage, Distribution
    • Temp, recirculation, sanitization → bioburden, endotoxin
  • Solution Preparation
    • Order of addition, mixing, pH and osmolarity adjustment, temperature → assay, stability, clarity
  • Glass/Ampoule/Vial Washing
    • Washer settings, final rinse quality → particulates, endotoxin
  • Depyrogenation (if applicable)
    • Tunnel temperature and belt speed → endotoxin reduction
  • Sterile Filtration
    • Integrity tests & filtration parameters → sterility
  • Aseptic Filling / Sealing
    • Headspace control, flame sealing or stoppering, crimping → CCI, fill volume, sterility
  • Terminal Sterilization (for SVP/LVP when applicable)
    • Autoclave cycle, F₀, load pattern → sterility, degradation
  • 100% Visual Inspection
    • Particulate matter and container defects → patient safety

H. Ointments / Creams

Key CQAs: Assay, CU, Microbial limits (topical) / Sterility (ophthalmic), Particle size (grittiness), Viscosity, Phase homogeneity, Degradation products, Appearance

Critical steps / CCPs:

  • Phase Preparation (Oil/Water)
    • Heating & mixing temperature/time → emulsion stability
  • Emulsification/Homogenization
    • Shear rate, time, cooling profile → droplet size, uniformity, viscosity
  • Addition of API & Heat-Sensitive Excipients
    • Temperature at addition, mixing uniformity → assay, CU, stability
  • Milling (if needed)
    • Gap, speed, number of passes → particle size, grittiness
  • Filling Operation
    • Pump setting, nozzle design, crimping of tubes → fill weight, CU, CCI
  • Microbial Control
    • Use of preserved vs. sterile product, environmental controls → microbial limits

I. Oral Liquid Syrup / Suspension

Key CQAs: Assay, CU, pH, Microbial limits, Preservative content, Degradation products, Viscosity, Clarity / Redispersibility, Sedimentation, Organoleptic properties

Critical steps / CCPs:

  • Water & Sugar Solution Preparation
    • Heating, dissolution, filtration → clarity, microbial control
  • API & Excipient Addition
    • Order & rate of addition; mixing speed → assay, CU, suspension stability
  • pH Adjustment
    • Addition of acids/bases in controlled manner → stability, taste, preservative efficacy
  • Homogenization (for suspensions)
    • Speed, time → droplet/particle size, redispersibility
  • Deaeration / Filtration
    • Vacuum deaeration, inline filters → foaming, particulate matter
  • Filling & Capping
    • Volume control, torque for caps, induction sealing → fill volume, CCI
  • Preservative Efficacy
    • Correct preservative levels → microbial limits over shelf-life

10 Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

error: Content is protected !!